Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q21
SBA

SBA — Single Best Answer · Review

Question 21

Feto-maternal medicine → Perinatology

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID 79fe78d2-0fd8-4471-90c1-699976e8a733

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Feto-maternal medicine
Topic
Perinatology
Subtopic 1
Diagnosis
Subtopic 2
Invasive
Subtopic 3
CVS
Question Type
SBA

Question

SSBA
Question Header
Confined placental mosaicism
Question Stem
Chorionic villus sampling is performed following an abnormal screening result. There is no fetal structural abnormality, but rapid QF-PCR testing suggests a chromosomal abnormality. What is the most appropriate next step before making an irreversible pregnancy management decision?

Options

A Repeat QF-PCR on the same sample only
B Await the full karyotype result
C Proceed immediately to termination on the rapid result alone
D Repeat maternal serum screening
E Ignore the result because CVS cannot diagnose aneuploidy

Explanation

Confined placental mosaicism occurs in approximately 1–2% of chorionic villus samples. When there is no corresponding fetal structural abnormality and rapid testing suggests a chromosomal abnormality, RCOG advises caution before an irreversible decision because the placental result may not represent the fetal karyotype. The full cytogenetic result should therefore be awaited and further fetal testing considered where appropriate.

Option Validity

A) Repeating the same rapid assay does not resolve the issue of confined placental mosaicism.

C) An irreversible decision should not be based solely on the rapid placental result in this situation.

D) Screening does not supersede definitive cytogenetic assessment after an abnormal invasive diagnostic result.

E) CVS is a definitive diagnostic procedure, but placental mosaicism can complicate interpretation.

Further Reading

Navaratnam K, Alfirevic Z; Royal College of Obstetricians and Gynaecologists. Amniocentesis and chorionic villus sampling: Green-top Guideline No. 8. BJOG. 2022;129:e1-e15.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
9.50
Destination
Site
Source
Amniocentesis and chorionic villus sampling: Green-top Guideline No. 8
Source Section
Laboratory considerations and confined placental mosaicism
Source Locator
RCOG Green-top Guideline No. 8, October 2021
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question